Methylenedioxybenzylamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

MDBZ, also known as 3,4-methylenedioxy-N-benzylamphetamine or as N-benzyl-MDA, is a chemical compound of the phenethylamine, amphetamine, MDxx, and N-benzylphenethylamine families related to MDA.[1][2] It is the N-benzyl derivative of MDA.[1][2]

Other namesMDBZ; 3,4-Methylenedioxy-N-benzylamphetamine; N-Benzyl-MDA
ATC code
  • None
Quick facts Clinical data, Other names ...
MDBZ
Clinical data
Other namesMDBZ; 3,4-Methylenedioxy-N-benzylamphetamine; N-Benzyl-MDA
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 1-(2H-1,3-benzodioxol-5-yl)-N-benzylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H19NO2
Molar mass269.344 g·mol−1
3D model (JSmol)
  • C1=C3C(=CC=C1CC(C)NCC2=CC=CC=C2)OCO3
  • InChI=1S/C17H19NO2/c1-13(18-11-14-5-3-2-4-6-14)9-15-7-8-16-17(10-15)20-12-19-16/h2-8,10,13,18H,9,11-12H2,1H3
  • Key:DWLUHTUYTBWOLO-UHFFFAOYSA-N
 ☒NcheckY (what is this?)  (verify)
Close

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDBZ's dose as greater than 150 mg orally and its duration as unknown.[1][2] According to Shulgin, MDBZ showed "little if any activity".[1]

Chemistry

Synthesis

The chemical synthesis of MDBZ has been described.[1]

Analogues

Analogues of MDBZ include MDA, MDMA, MDCPM, benzphetamine, benzylone (bk-MDBZ), and 2C2-NBOMe, among others.[1][2]

History

MDBZ was first described in the scientific literature by Alexander Shulgin and colleagues in 1980.[3] Subsequently, it was described in greater detail by Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.[1]

Society and culture

In an episode of the British spoof documentary TV show Brass Eye, David Amess MP was fooled into recording a warning against a fictitious new drug called "cake". When asked a parliamentary question about it, the Home Office incorrectly assumed Amess was referring to MDBZ.[4]

United Kingdom

MDBZ is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[5]

See also

References

Related Articles

Wikiwand AI